Literature DB >> 11149747

The differential influence of EGF, IGF-I, and TGF-beta on the invasiveness of human breast cancer cells.

G M Tong, T T Rajah, J T Pento.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11149747     DOI: 10.1290/1071-2690(2000)036<0493:TDIOEI>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  12 in total

1.  Influence of antiestrogens on EGF- and IGF-I-mediated proliferation of human breast cancer cells.

Authors:  G M Tong; T T Rajah; J T Pento
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-01       Impact factor: 2.416

Review 2.  Growth factors and cell movement.

Authors:  E Gherardi
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

Review 3.  Transforming growth factors and the regulation of cell proliferation.

Authors:  R M Lyons; H L Moses
Journal:  Eur J Biochem       Date:  1990-02-14

4.  Influence of antiestrogens on the invasiveness and laminin attachment of breast cancer cells.

Authors:  T T Rajah; J T Pento
Journal:  Cancer Invest       Date:  1999       Impact factor: 2.176

5.  Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.

Authors:  S M Abbas Abidi; E W Howard; J J Dmytryk; J T Pento
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

6.  Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

Authors:  D R Welch; A Fabra; M Nakajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.

Authors:  G Zugmaier; B W Ennis; B Deschauer; D Katz; C Knabbe; G Wilding; P Daly; M E Lippman; R B Dickson
Journal:  J Cell Physiol       Date:  1989-11       Impact factor: 6.384

8.  Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

Authors:  C L Arteaga; S D Hurd; A R Winnier; M D Johnson; B M Fendly; J T Forbes
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 9.  Insulin-like growth factor expression in breast cancer epithelium and stroma.

Authors:  K J Cullen; A Allison; I Martire; M Ellis; C Singer
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 10.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.

Authors:  J G Klijn; P M Berns; P I Schmitz; J A Foekens
Journal:  Endocr Rev       Date:  1992-02       Impact factor: 19.871

View more
  4 in total

1.  Antiestrogen inhibition of EGF-mediated invasiveness of human breast cancer cells.

Authors:  G M Tong; T T Rajah; X Zang; J T Pento
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-10       Impact factor: 2.416

2.  Lipids and proteins act in opposing manners to regulate polyomavirus infection.

Authors:  Mengding Qian; Billy Tsai
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

3.  Anti-angiogenic therapy induces integrin-linked kinase 1 up-regulation in a mouse model of glioblastoma.

Authors:  Chiara Verpelli; Giulio Bertani; Valentina Cea; Monica Patti; Andreas Bikfalvi; Lorenzo Bello; Carlo Sala
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

4.  Modulation of integrin-linked kinase (ILK) expression in human oesophageal squamous cell carcinoma cell lines by the EGF and TGFbeta1 growth factors.

Authors:  Glenn A Driver; Robin B Veale
Journal:  Cancer Cell Int       Date:  2006-04-27       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.